Sp110, a polypeptide component of the nuclear body

Details Sp110, a polypeptide component of the nuclear body Sp110, a polypeptide component of the nuclear body

2006-08-08

2006-08-08

Minnifield, N. M. (Department: 1645)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C530S300000, C530S324000, C530S344000, C530S358000, C424S185100

Reexamination Certificate

active

07087717

ABSTRACT:
Cloning and characterization of a full length cDNA encoding Sp110 (speckled 110), a novel 110 kDa polypeptide, is disclosed. It is disclosed that Sp110 is a component of the nuclear body, is expressed in leukocytes, and is also expressed in other types of cells, including endothelial cells, smooth muscle cells, liver cells and heart cells, after contact with certain cytokines. The disclosure also includes the following: Sp140 recruits Sp110 to the nuclear body, Sp110 functions as an activator of gene transcription, and Sp110 serves as a nuclear hormone receptor co-activator. Sp110 DNAs, polypeptides, antibodies are disclosed. Also disclosed are Sp110-related screening methods and clinical diagnostic methods.

REFERENCES:
patent: 5652122 (1997-07-01), Frankel et al.
patent: 6183988 (2001-02-01), Bloch et al.
patent: 6783961 (2004-08-01), Edwards et al.
patent: 2003/0216548 (2003-11-01), Bloch et al.
patent: 2004/0171012 (2004-09-01), Yue et al.
patent: 2004/0171823 (2004-09-01), Nadler et al.
patent: WO 98/14569 (1998-04-01), None
patent: WO 02/08383 (2002-01-01), None
Negorev et al, J. Cell Science, 2000, 114:59-68.
Rasheed et al, Experimental Cell Research, 2002, 277:152-160.
Zimber et al, Cellular Signalling, 2004, 16:1085-1104.
Strausberg et al, PNAS, USA, 2002, 99/26:16899-16903.
Wiesmeijer et al, J. Structural Biology, 2002, 140/1-3:180-188 abstract only.
Muller et al, J. Virology, 1999, 73/6:5137-5143 abstract only.
Sternsdorf et al, JBC, 1999, 274/18:12555-12566.
Regad et al, Oncogene, 2001, 20:7274-7486.
Seeler et al, current Opinion in Genetics and Development, 1999, 9:362-367.
Puvion-Dutilleul et al, Experimental Cell Research, 1995, 221:448-461.
Liettig et al, J. Hepatology, 1998, 28:824-828.
International Search Report for corresponding international application no. PCT/US01/23248 (Jul. 24, 2003).
Bloch et al., Database GenBank, Accession No. AF280095, Submitted Jun. 20, 2000.
Bloch et al., “Sp110 Localizes to the PML-Sp100 Nuclear Body and May Function as a Nuclear Hormone Receptor Transcriptional Coactivator,”Mol. Cell. Biol.20:6138-6146, 2000.
Neto et al., “Shotgun sequencing of the human transcriptome with ORF expressed sequence tags,”PNAS97:3491-3496, 2000.
The Sanger Centre et al., “Progress Toward a Complete Human Genome Sequence,”Genome Res.8:1097-1108, 1998.
Seeler et al., “Common Properties of Nuclear Body Protein SP100 and TIF1 α Chromatin Factor: Role of SUMO Modification,”Mol. Cell. Biol.21:3314-3324, 2001.
Aasland et al., “The PHD finger: implications for chromatin-mediated transcriptional regulation,” Trends Biochem. Sci. 20:56-59 (1995).
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,” Nucleic Acids Research 25: 3389-3402 (1997).
Ascoli et al., “Identification of a novel nuclear domain.,” J. Cell Biol. 112: 785-795 (1991).
Bloch et al., “Serum antibodies to heat shock protein 70 in sensorineural hearing loss,” Archives of Otolaryngology-Head and Neck Surgery 121:1167-1171 (1995).
Bloch et al., “Identification and characterization of a leukocyte-specific component of the nuclear body,” J. Biol. Chem. 271: 29198-29204 (1996).
Bloch et al., “Structural and functional heterogeneity of nuclear bodies,” Mol. Cell. Biol. 19:4423-4430 (1999).
Bonfanti et al., “p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth,” Cancer Res. 57:1442-1446 (1997).
Brownell et al., “Tetrahymena Histone Acetyltransferase A: A Homolog to Yeast Gcn5p Linking Histone Acetylation to Gene Activation,” Cell 84: 843-851 (1996).
Dent et al., “LYSP100-associated nuclear domains (LANDs): description of a new class of subnuclear structures and their relationship to PML nuclear bodies,” Blood 88:1423-1436 (1996).
Dikstein et al., “TAFII250 Is a Bipartite Protein Kinase That Phosphorylates the Basal Transcription Factor RAP74,” Cell 84:781-790 (1996).
Doucas et al., “Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.,” Proc. Natl. Acad. Sci. USA 96:2627-2632 (1999).
Fraser et al., “The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors.,” J. Biol. Chem. 273:16199-16204 (1998).
Gibson et al., “The APECED polyglandular autoimmune syndrome protein, AIRE-1, contains the SAND domain and is probably a transcription factor,” Trends Biochem. Sci. 23:242-244 (1998).
Giles et al., “Conjunction dysfunction: CBP/p300 in human disease,” Trends Genet 14:178-183 (1998).
Gross et al., “DEAF-1, a novel protein that binds an essential region in a Deformed response element,” EMBO J. 15:1961-1970 (1996).
Gulick et al., “The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression,” Proc. Natl. Acad. Sci., USA 91:11012-11016 (1994).
Haynes et al., “The bromodomain: a conserved sequence found in human, Drosphila and yeast proteins,” Nucl. Acids Res. 20:2603 (1992).
Hodges et al., “Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies,” Am. J. Hum. Genet. 63:297-304 (1998).
Ishov et al., “Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environnment,” J. Cell. Biol 138:5-16 (1997).
Jeanmougin et al., “The bromodomain revisited,” Trends Biochem. Sci. 22:151-153 (1997).
Kadereit et al., “Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins,” J. Biol. Chem. 268:24432-2441 (1993).
Kersten et al., “Peroxisome proliferator activated receptor α mediates the adaptive response to fasting,” J. Clin. Invest. 103:1489-1498 (1999).
LaMorte et al., “Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body,” Proc. Natl. Acad. Sci. USA 95:4991-4996 (1998).
Laurent et al., “The yeast SNF2/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation,” Genes Dev. 7:583-591 (1993).
Le Douarin et al., “A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors,” EMBO J. 15:6701-6715 (1996).
Lehming et al., “Chromatin components as part of a putative transcriptional repressing complex,” Proc. Natl. Acad. Sci. USA 95:7322-7326 (1998).
Mahl et al., “Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years,” J. Hepatol. 20:707-713 (1994).
Melnick et al., “Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia,” Blood 93:3167-3215 (1999).
Nagamine et al., “Positional cloning of the APECED gene,” Nature Genetics 17:393-397 (1997).
Quignon et al., “PML induces a novel caspase-independent death process,” Nature Genetics 10:259-265 (1998).
Seeler et al., “Interaction of SP100 with HP1 proteins: a link between the promyelocytic leukemia-associated nuclear bodies and the chromatin compartment,” Proc. Natl. Acad. Sci. USA 95:7316-7321 (1998).
Smith et al., “Single-step purification of polypeptides expressed inEscherichia colias fusions with glutathione S-transferase,” Gene 67:31-40 (1988).
Springer et al., “Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis,” Am. J. Gastroenterol. 94:47-53 (1999).
Sternsdorf et al., “Nuclear dots: actors on many stages,” Immunobiology 198:307-331 (1997).
Szostecki et al., “Isolation and characterization of cDNA encoding a human nuclear antigen predominantly

Affiliated with

Also associated with

Rating

Sp110, a polypeptide component of the nuclear body does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sp110, a polypeptide component of the nuclear body, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sp110, a polypeptide component of the nuclear body will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3695785